Patent Assignment
Reel/Frame 049175/0877
Assignment of Assignor's Interest
Recorded: 2019-05-14
Pages: 3
Assignee
ALETHIA BIOTHERAPEUTICS INC.
141 PRESIDENT-KENNEDY AVENUE, SUITE SB-5100, MONTREAL, QUEBEC, H2X 1Y4, CANADA
Covered Property
(1)
Antibodies That Specifically Block the Biological Activity of a Tumor Antigen
Application:
15/833,753 →
Publication:
US 2018/0369269
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
May 14, 2019
From: SULEA, TRAIAN
To: NATIONAL RESEARCH COUNCIL OF CANADA
Reel/Frame 049175/0874 →
Assignment of Assignor's Interest
May 14, 2019
From: NATIONAL RESEARCH COUNCIL OF CANADA
To: ALETHIA BIOTHERAPEUTICS INC.
Reel/Frame 049175/0898 →
Assignment of Assignor's Interest
May 14, 2019
From: ALETHIA BIOTHERAPEUTICS INC.
To: ADC THERAPEUTICS SA
Reel/Frame 049175/0901 →
Security Interest
May 19, 2020
From: ADC THERAPEUTICS SA
To: DEERFIELD PARTNERS, L.P., AS GRANTEE
Reel/Frame 052696/0247 →
Security Interest
Jun 30, 2020
From: ADC THERAPEUTICS SA
To: DEERFIELD PARTNERS, L.P.
Reel/Frame 053094/0602 →
Termination and Release of Patent Security Agreement
Aug 16, 2022
From: DEERFIELD PARTNERS, L.P.
To: ADC THERAPEUTICS SA
Reel/Frame 061200/0750 →